1 of 11

Slide Notes

DownloadGo Live

Viberzi

Published on Jun 08, 2017

No Description

View Outline

MORE DECKS TO EXPLORE

PRESENTATION OUTLINE

1.

Increased Risk of Pancreatitis

Manufactured by Allergan
2.

Viberzi was initially approved in May 2015

Photo by quimby
3.

Irritable Bowel Syndrome

a condition marked by constipation or diarrhea
Viberzi (Eluxadoline) is approved for diarrhea predominant IBS.
Photo by tranchis
4.

25,000,000

men & women are affected by IBS
Photo by H o l l y.
5.

Pancreatitis is an inflammation of the pancreas.

Photo by PHOTOPHONES
6.

Pancreatitis symptoms

  • Stomach pain
  • Food intolerance
  • Disabling nausea
Photo by Stefanotshcki!
7.

The FDA received 120 reports of serious pancreatitis and 2 fatal cases

8.

Pancreatitis usually occurs after 2 weeks of taking Viberzi

Photo by hypercreativity
9.

The deaths occurred after 1 or 2 doses in 48

Photo by Shreyans Bhansali
10.

The FDA recommends that physicians consider alternatives before prescribing Viberzi to patients

Photo by rpongsaj
11.

Untitled Slide

B Fonseca

Haiku Deck Pro User